dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada πππππ¬π π©π¨π¬π’ππ’π¨π§ π¨π πππ-π π’π§π‘π’ππ’ππ¨π«π¬ (π.π ., π¬π’πππ π₯π’π©ππ’π§, π¬ππ±ππ π₯π’π©ππ’π§, π₯π’π§ππ π₯π’π©ππ’π§, ππ₯π¨π π₯π’π©ππ’π§, π―π’π₯πππ π₯π’π©ππ’π§) π’π§ ππ‘π ππππ πππ ππππ§πππ«ππ¬ π¨π Independent Nurse - GLP-1 and
Description
[DOI] [PubMed] [Google Scholar] 21.Su J., et al
Finck, B
GLP-1 also regulates gastric motility by slowing gastric emptying in a dose-dependent manner, helping to control postprandial glucose levels
38: 665673 [DOI] [PubMed] [Google Scholar] 160.Meier JJ, Goetze O, Anstipp J, et al
Overall, current guidelines recognize liraglutide and semaglutide as first-line pharmacotherapy options for severe adolescent obesity when combined with lifestyle therapy
